Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsIV (INFUSION)Standard

ORENCIA

ABATACEPT

Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ORENCIA is listed in Drugs@FDA under application 125118 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ABATACEPT Form and strength INJECTABLE; IV (INFUSION) - 250MG Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2024-05-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORENCIA is listed in Drugs@FDA under application 125118 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ABATACEPT Form and strength INJECTABLE; IV (INFUSION) - 250MG Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2024-05-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.